OFLOXACIN
OFLOXACIN is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: OFLOXACIN; Generic name: OFLOXACIN; Drug class: Quinolone Antimicrobial [EPC].
| Brand name | OFLOXACIN |
|---|---|
| Generic name | OFLOXACIN |
| Drug class | Quinolone Antimicrobial [EPC] |
| Manufacturer | Nivagen Pharmaceuticals, Inc. |
| Used for | INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of ofloxacin tablets, USP and other antibacterial drugs, ofloxacin tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Ofloxacin tablets, USP are indicated for the treatment of adults with mild to moderate infections (unless otherwise indicated |
| Dosage | DOSAGE AND ADMINISTRATION The usual dose of ofloxacin tablets is 200 mg to 400 mg orally every 12 h as described in the following dosing chart. These recommendations apply to patients with normal renal function (i.e., creatinine clearance > 50 mL/min). For patients with altered renal function (i.e., creatinine clearance ≤ 50 mL/min), see the Patients With Impaired Renal Function subsection. Infection DUE TO THE DESIGNATED PATHOGENS (see INDICATIONS AND USAGE ). Unit Dose Frequency Duration Daily |
| Warnings | WARNINGS Disabling and Potentially Irreversible Serious Adverse Reactions Including Tendinitis and Tendon Rupture, Peripheral Neuropathy, and Central Nervous System Effects Fluoroquinolones, including ofloxacin, have been associated with disabling and potentially irreversible serious adverse reactions from different body systems that can occur together in the same patient. Commonly seen adverse reactions include tendinitis, tendon rupture, arthralgia, myalgia, peripheral neuropathy, and central |
| Active ingredient(s) | OFLOXACIN |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1779c568-d7bb-4bd5-bc29-13bd52ba8a0a |